This XRCC3 exon 7 polymorphism has previously shown a significant association with melanoma (Winsey et al, 2000), bladder cancer (Matullo et al, 2001a) and SCCHN (Shen et al, 2002). This evidence concerns the gene XRCC3 and melanoma.